Silexion Therapeutics Corp

Contributing Author

Recent Articles by Silexion Therapeutics Corp

May-29	Silexion Therapeutics Announces Groundbreaking Preclinical Results: SIL204 Shows Strong Efficacy in Pancreatic, Colorectal, and Lung Cancers SLXN GlobeNewswire
May-21	Silexion Therapeutics Completes Key Preclinical Studies Exploring SIL204's Potential Impact on Colorectal and Lung Cancer SLXN GlobeNewswire
May-13	Silexion Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update SLXN GlobeNewswire